Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 241.39 K575.47 K224 K181.09 K240.08 K1.28 M 1.92 M Research & development —————— — Operating income -241.39 K-575.47 K-224 K-181.09 K-240.08 K-1.28 M -1.92 M Non-Operating Income, Total 1.22 M1.22 M1.24 M1.15 M1.06 M878.34 K 4.33 M Interest expense, net of interest capitalized —————— — Non-Operating Income, excl. Interest Expenses 1.22 M1.22 M1.24 M1.15 M1.06 M878.34 K 4.33 M Unusual income/expense —————— — Pretax income 974.31 K645.82 K1.01 M972.67 K821.71 K-400.07 K 2.41 M Equity in earnings —————— — Taxes —————— — Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations 974.31 K645.82 K1.01 M972.67 K821.71 K-400.07 K 2.41 M Discontinued operations —————— — Net income 974.31 K645.82 K1.01 M972.67 K821.71 K-400.07 K 2.41 M Dilution adjustment ————1.06 M1.74 M — Preferred dividends ————1.06 M938.34 K — Diluted net income available to common stockholders 974.31 K645.82 K1.01 M972.67 K821.71 K400.07 K 3.21 M Basic earnings per share (Basic EPS) 0.060.040.070.060.06-0.03 0.16 Diluted earnings per share (Diluted EPS) 0.060.040.070.060.06-0.03 0.16 Average basic shares outstanding 4.42 M4.42 M4.42 M4.42 M4.42 M4.42 M — Diluted shares outstanding 4.42 M4.42 M4.42 M4.42 M4.42 M4.42 M — EBITDA —————— — EBIT —————— — Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) —————— —